Your Translational Science Partner
At Pharmidex, we go beyond traditional CRO services—combining scientific expertise, flexibility, and translational insight to help you advance your discoveries with confidence.
Expert Collaboration
We support toxicology, PK/PD, efficacy, and safety studies across key therapeutic areas. Our scientists work alongside your team to design robust studies, validate models, and generate meaningful, decision-driving data.
Flexible & Rigorous Execution
Every study is guided by experienced scientific leadership and built on quality-controlled workflows. We provide real-time updates and adapt study designs as your research evolves ensuring your program stays on track.
Fast & Client-Focused
We prioritize speed without compromising scientific integrity. Our collaborative approach and responsiveness make us a trusted partner for both new and returning clients.
Seamless Data & Reporting
Access your data securely in real time, with clear, structured reporting at every stage. Post-study consultations help you interpret results and define your next steps.
Advancing Your Research, Together
From early discovery to development, Pharmidex supports your success with precision, transparency, and scientific excellence.
2013
The establishment of a presence within Stevenage Bioscience Catalyst, placing Pharmidex at the heart of one of the UK’s leading biotech hubs, fostering collaboration with innovative biotech companies
2016
Early involvement with Eastman Kodak Company, providing a strong scientific and infrastructure foundation.
2017
Recognition as SME Hertfordshire Business Awards Winner (2017), reflecting excellence in business performance and innovation within the regional life sciences sector.
2018
International Expansion
Pharmidex extended its global footprint with the opening of its Bern, Switzerland office in 2018, enabling closer collaboration with European partners and enhancing its ability to support international drug development programs.
2020
Medicines and Healthcare products Regulatory Agency recognition in 2020, reinforcing adherence to high regulatory standards.
2023
Achievement of AAALAC International accreditation in 2023, demonstrating commitment to the highest standards of animal care, welfare, and scientific integrity.
2026
A Trusted Global Partner
From its origins as a specialized preclinical CRO, Pharmidex has grown into a globally trusted partner, supporting drug discovery and development programs across a wide range of therapeutic areas.
Today, the company has contributed to over 17,000 studies, reflecting its extensive experience, scientific depth, and long-standing commitment to delivering high-quality, decision-enabling data.
Pharmidex Integrated Preclinical Platform to Optimize the Efficacy and Safety Leads
Pharmidex Integrated Preclinical Platform to Optimize the Efficacy and Safety of Leads
